These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35704700)

  • 1. Syndecan-1 in liver pathophysiology.
    Reszegi A; Tátrai P; Regős E; Kovalszky I; Baghy K
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C289-C294. PubMed ID: 35704700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14.
    Regős E; Abdelfattah HH; Reszegi A; Szilák L; Werling K; Szabó G; Kiss A; Schaff Z; Kovalszky I; Baghy K
    Matrix Biol; 2018 Aug; 68-69():474-489. PubMed ID: 29454902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
    Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
    Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan-1 in Liver Diseases.
    Regős E; Karászi K; Reszegi A; Kiss A; Schaff Z; Baghy K; Kovalszky I
    Pathol Oncol Res; 2020 Apr; 26(2):813-819. PubMed ID: 30826971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
    Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
    Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate regulates proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells via syndecan-1.
    Zeng Y; Liu X; Yan Z; Xie L
    Prog Biophys Mol Biol; 2019 Nov; 148():32-38. PubMed ID: 29180036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.
    Stanford KI; Bishop JR; Foley EM; Gonzales JC; Niesman IR; Witztum JL; Esko JD
    J Clin Invest; 2009 Nov; 119(11):3236-45. PubMed ID: 19805913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx.
    Grigorov B; Reungoat E; Gentil Dit Maurin A; Varbanov M; Blaising J; Michelet M; Manuel R; Parent R; Bartosch B; Zoulim F; Ruggiero F; Pécheur EI
    Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27930836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.
    Zhang F; Sodroski C; Cha H; Li Q; Liang TJ
    Gastroenterology; 2017 Jan; 152(1):257-270.e7. PubMed ID: 27693511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecans in heart fibrosis.
    Lunde IG; Herum KM; Carlson CC; Christensen G
    Cell Tissue Res; 2016 Sep; 365(3):539-52. PubMed ID: 27411689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proteoglycans in the liver].
    Kovalszky I; Dudás J; Gallai M; Hollósi P; Tátrai P; Tátrai E; Schaff Z
    Magy Onkol; 2004; 48(3):207-13. PubMed ID: 15520870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
    Kosir MA; Quinn CC; Wang W; Tromp G
    J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1.
    Hollósi P; Váncza L; Karászi K; Dobos K; Péterfia B; Tátrai E; Tátrai P; Szarvas T; Paku S; Szilák L; Kovalszky I
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32977498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteoglycans in liver cancer.
    Baghy K; Tátrai P; Regős E; Kovalszky I
    World J Gastroenterol; 2016 Jan; 22(1):379-93. PubMed ID: 26755884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis.
    Kumar Katakam S; Tria V; Sim WC; Yip GW; Molgora S; Karnavas T; Elghonaimy EA; Pelucchi P; Piscitelli E; Ibrahim SA; Zucchi I; Reinbold R; Greve B; Götte M
    FEBS J; 2021 Jan; 288(2):486-506. PubMed ID: 32367652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Syndecan-1 in Chronic Liver Diseases: Correlation With Hepatic Fibrosis.
    Charchanti A; Kanavaros P; Koniaris E; Kataki A; Glantzounis G; Agnantis NJ; Goussia AC
    In Vivo; 2021; 35(1):333-339. PubMed ID: 33402482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
    Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
    J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-1 (CD138), Carcinomas and EMT.
    Couchman JR
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.